This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Niels Svenstrup, Ph.D.
SVP Chemistry, Manufacturing and Controls at PepGen
Speaker

Profile

Niels Svenstrup currently serves as Senior Vice President of Chemistry and Manufacturing at PepGen. Niels has more than 20 years of Pharma and Biotech industry experience in Pharmaceutical Research & Development and his work has resulted in the invention of numerous drug candidates of which several are currently in clinical development. Prior to joining PepGen he served in a variety of R&D leadership roles including SVP Development at Cydan, Director of CMC at Ascendis Pharma, Head of Department, Medicinal Chemistry at H. Lundbeck A/S, and R&D Project Leader at Bayer Pharma.

Agenda Sessions

  • Enhanced Delivery Oligonucleotides: An Update on Preclinical and Clinical Progress

    11:15am